Pei Wang, PhD
img_Pei Wang
PROFESSOR | Genetics and Genomic Sciences
High dimensional inference & integrative genomics
I am interested in developing statistical and computational methods to address scientific questions based on data from high throughput biology/genetics experiments. The ultimate goal is to enhance our understanding of cell activities and disease initiation/progression to a system level by integrating information from diverse biological sources (genetics/genomics, proteomics, and phenotypes). Towards this goal, eff orts have been made to properly model each individual type of data and to effectively characterize interactions among different biology molecules. These eff orts all borrow strength from and contribute to the developments of high dimensional inference, a challenging yet thriving field in modern statistics. For more details about Dr. Wang’s research, visit http://research.mssm.edu/wanglab/

BS, Peking University

PhD, Stanford University

Publications

Selected Publications

Epstein-Barr Virus Exposure Precedes Crohn's Disease Development. Anubhab Nandy, Francesca Petralia, Chad K. Porter, Stephen Elledge, Rajsavi Anand, Kenneth Croitoru, Gus Dunn, Evida Dennis-Heyward, Ally Eran, Michael Field, Katherine Freer, Benjamin E. Gewurz, Abigail Glick, Bruce Horwitz, Tomasz Kula, Ryan Kelly, Sun ho Lee, Renee M. Laird, Natalie Pica, Tamar Parmet, Mark Riddle, Joana Torres, Williams Turpin, Pei Wang, Sydney Whitcomb, Jean Frederic Colombel, Scott B. Snapper. Gastroenterology

Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets. Iga Kołodziejczak-Guglas, Renan L.S. Simões, Emerson de Souza Santos, Elizabeth G. Demicco, Rossana N. Lazcano Segura, Weiping Ma, Pei Wang, Yifat Geffen, Erik Storrs, Francesca Petralia, Antonio Colaprico, Felipe da Veiga Leprevost, Pietro Pugliese, Michele Ceccarelli, Houtan Noushmehr, Alexey I. Nesvizhskii, Bożena Kamińska, Waldemar Priebe, Jan Lubiński, Bing Zhang, Alexander J. Lazar, Paweł Kurzawa, Mehdi Mesri, Ana I. Robles, Alicia Francis, Amanda G. Paulovich, Anna P. Calinawan, Antonio Iavarone, Arul M. Chinnaiyan, Bo Wen, Boris Reva, Brian J. Druker, Caleb M. Lindgren, Chandan Kumar-Sinha, Chelsea J. Newton, Chen Huang, Chet Birger, Corbin Day, D. R. Mani, Daniel Cui Zhou, Daniel W. Chan, David Fenyö, David I. Heiman, Dmitry Rykunov, Emily Huntsman, Eric E. Schadt, Eric J. Jaehnig, Shrabanti Chowdhury, Xiaoyu Song, Zeynep H. Gümüş. Cell Genomics

Rbm39 ameliorates metabolic dysfunction-associated steatotic liver disease by regulating Apob and Fabp4. Chunbo Zhuang, Fangfang Cui, Jin Chen, Dezhi He, Ting Sun, Pei Wang. Biochimica et Biophysica Acta - Molecular Basis of Disease

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Wang did not report having any of the following types of financial relationships with industry and other outside entities during 2024 and/or 2025: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.